FindTrial
Sign In

Study on the detection of peripheral blood immune cells and cytokines in serum in patients with lung cancer and the clinical value in predicting of radiotherapy sensitivity

Study on the detection of peripheral blood immune cells and cytokines in serum in patients with lung cancer and the clinical value in predicting of radiotherapy sensitivity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016155
Enrollment
Unknown
Registered
2018-05-15
Start date
2018-05-17
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Sensitivie to radiation:Flow Cytometry
Insensitivie to radiation:Flow Cytometry

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Volunteered as subjects and signed informed consent; 2. Aged over 18 years; 3. Stage III non small cell lung cancer patients; 4. Patients with clear biopsy diagnosis; 5. Radiotherapy was planned for lung lesions, and no other radiotherapy was accepted.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with benign lung tumor by pathological examination; 2. People have other malignant tumor; 3. Refused to sign the informed consent; 4. Unavailable for follow up; 5. The researchers believe that the other condition to lead to that they don't fit into the group.

Design outcomes

Primary

MeasureTime frame
One month after radiation;One month after radiation;One month after radiation;One month after radiation;—

Countries

China

Contacts

Public ContactLiu Jun

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

zongy1990@163.com+86 18827349083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026